Handmade quality · Free shipping over $75 · Explore the atelier

BRAF inhibitor - CAS# 918505-61-0 mostat Hydrochloride a promising novel medicine for

SKU: 82610506592

4.7
USD120.00 USD169.00

Pay in 4 interest-free payments of $30.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 28 - Aug 2

Description

a promising novel medicine for psychiatric diseases

InChiKey: VFOKSTCIRGDTBR-UHFFFAOYSA-N

InChi: InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer

BMS-794833 exhibited dose-dependent anti-tumor activity against multiple tumor types without overt toxicities at efficacious dose levels

BRAF inhibitor - CAS# 918505-61-0 mostat Hydrochloride a promising novel medicine forVemurafenib Analog is a potent BRAF inhibitor and the isomer of Vemurafenib. Vemurafenib, also known as PLX4032, RG7204 or RO5185426, is an orally bioavailable, ATP competitive, small molecule inhibitor of BRAF(V600E) kinase with potential antineoplastic activity. Vemurafenib received FDA approval for the treatment of late stage melanoma on August 17, 2011. Product information CAS Number: 918505 61 0 Molecular Weight: 456. 47 Formula: C22H18F2N4O3S

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products